Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma

Annals of Surgical Oncology

Volumn 6, Issue 6, 1999, Pages 591-598

  Mann, G Bruce ^a,b   Rush Port, Elisa ^a   Rizza, Christine ^a   Tan, Lee K ^a,c   Borgen, Patrick I ^a   Van Zee, Kimberly J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Axillary dissection; Axillary lymph node metastases; Early breast cancer; Microinvasive breast cancer; Minimal breast cancer; Prognosis disease free survival; Regional metastases; Sentinel node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; PATHOLOGY; RECURRENT CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 13044316546     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0591-5     Document Type: Article

References (35)

1. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-4.
2. Silverstein M, Gierson E, Waisman J, Senofsky G, Colburn W, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994;73:664-7.
3. Cady B. Is axillary lymph node dissection necessary in routine management of breast cancer? No. The Breast Journal 1997;3: 246-60.
4. Chontos A, Maher D, Ratzer E, Fenoglio M. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 1997;184:493-8.
5. Velanovich V. Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions. Ann Surg Oncol 1998;5:131-9.
6. Mustafa I, Bland K. Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol 1998;5:4-8.
7. Walls J, Boggis C, Wilson M, Asbury D, Roberts J, Bundred N, Mansel R. Treatment of the axilla in patients with screen-detected breast cancer. Br J Surg 1993;80:436-8.
8. Silverstein M, Gierson E, Waisman J, Colbum W, Gamagami P. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995;180:700-4.
9. Dowlatshahi K, Snider H, Kim R. Axillary node status in nonpalpable breast cancer. Ann Surg Oncol 1995;2:424-8.
10. Barth A, Craig P, Silverstein M. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1997;79: 1918-22.
11. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63:181-7.
12. Giuliano A, Barth A, Spivack B, Beitsch PD, Evans SW. Incidence, and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 1996;183:185-9.
13. Shetty M, Reiman H Jr. Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997;23:139-41.
14. White R, Vezeridis M, Konstadoulakis M, Cole B, Wanebo H, Bland K. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996;183:575-82.
15. Rush Port E, Tan L, Borgen P, Van Zee K. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 1998;5:23-7.
16. Robinson D, Senofsky G, Ketcham A. Role, and extent of lymphadenectomy for early breast cancer. Semin Surg Oncol 1992;8:78-82.
17. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996;3:233-4.
18. Shetty M. Axillary lymph node metastasis in carcinoma of the breast. J Am Coll Surg 1997;184:671-2.
19. Baxter N, McCready D, Chapman J, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 1996;3:235-40.
20. Sosa J, Diener-West M, Gusev Y, Choti M, Lange J, Dooley W, Zeiger M. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 1998;5:140-9.
21. Giuliano A, Jones R, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
22. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-67.
23. Kiricuta C, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992;69:2496-501.
24. Chadha M, Chabon A, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1993;73:350-3.
25. Fein D, Fowble B, Hanlon A, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J surg Oncol 1997;65:34-9.
26. Olivotto I, Jackson J, Mates D, Anderson S, Davidson W, Bryce C, Ragaz J. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer 1998;83:948-55.
27. Leitner S, Swern A, Weinberger D, Duncan L, Hutter R. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (Tla,b N0 M0). Cancer 1995;76:2266-74.
28. International Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-68.
29. Kinne D, Petrek J, Osborne M, Fracchia A, DePalo A, Rosen P. Breast carcinoma in situ. Arch Surg 1989;124:33-6.
30. Wong J, Kopald K, Morton D. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990;125:1298-302.
31. Silverstein M, Waisman J, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 1990;66:102-8.
32. Solin L, Fowble B, Yeh I, Kowalyshyn M, Schultz D, Weiss M, Goodman R. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Blol Phys 1992;23:961-8.
33. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985; 5:17-21.
34. Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Arch Surg 1987;122:1244-47.
35. Ruffin WK, Stacey-Clear A, Younger J, Hoover HC Jr. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995;180:245-51.